Maternal obesity is associated with chorioamnionitis and earlier indicated preterm delivery among expectantly managed women with preterm premature rupture of membranes

J Matern Fetal Neonatal Med. 2019 Jan;32(2):271-278. doi: 10.1080/14767058.2017.1378329. Epub 2017 Sep 22.

Abstract

Objective: To determine the association between maternal obesity and delivery due to chorioamnionitis prior to labor onset, among expectantly managed women with preterm premature rupture of membranes (pPROM).

Methods: This was a secondary analysis of a multicenter randomized trial of magnesium sulfate versus placebo to prevent cerebral palsy or death among offspring of women with anticipated delivery at 24-31-week gestation. After univariable analysis, Cox proportional hazard evaluated the association between maternal obesity and chorioamnionitis, while Laplace regression investigated how obesity affects the gestational age at delivery of the first 20% of women developing the outcome of interest.

Results: A total of 164 of the 1942 women with pPROM developed chorioamnionitis prior to labor onset. Obese women had a 60% increased hazard of developing such complication (adjusted HR 1.6, 95%CI 1.1-2.1, p = .008), prompting delivery 1.5 weeks earlier, as the 20th survival percentile was 27.2-week gestation (95%CI 26-28.6) among obese as opposed to 28.8 weeks (95%CI 27.4-30.1) (p = .002) among nonobese women.

Conclusions: Maternal obesity is a risk factor for chorioamnionitis prior to labor onset. Future studies will determine if obesity is important enough to change the management of latency after pPROM according to maternal BMI.

Keywords: Obesity; chorioamnionitis; indicated preterm delivery; pregnancy.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Cesarean Section / statistics & numerical data
  • Chorioamnionitis / epidemiology*
  • Chorioamnionitis / therapy
  • Female
  • Fetal Membranes, Premature Rupture / epidemiology*
  • Fetal Membranes, Premature Rupture / therapy*
  • Humans
  • Infant, Newborn
  • Magnesium Sulfate / therapeutic use
  • Obesity / complications
  • Obesity / epidemiology*
  • Obesity / therapy
  • Pregnancy
  • Pregnancy Complications / epidemiology*
  • Pregnancy Complications / therapy
  • Pregnancy Outcome / epidemiology
  • Premature Birth / epidemiology*
  • Premature Birth / therapy
  • Retrospective Studies
  • Time Factors

Substances

  • Magnesium Sulfate

Supplementary concepts

  • Preterm Premature Rupture of the Membranes